WallStreetZenWallStreetZen

NASDAQ: MPLT
Maplight Therapeutics Inc Stock Ownership - Who owns Maplight Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Maplight Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Catalyst4 Inc10% Owner2026-07-301,000,000$13.00
$13.00MBuy
Catalyst4 Inc10% Owner2026-07-293,000$12.63
$37.89kBuy
Troy CoxDirector2026-07-2815,620$9.52
$148.70kBuy
Catalyst4 Inc10% Owner2026-07-28141,088$10.74
$1.52MBuy
Catalyst4 Inc10% Owner2026-07-2865,137$11.69
$761.39kBuy
Anatol KreitzerCXO2026-07-172,833$37.05
$104.96kSell
Anatol KreitzerCXO2026-07-1714,140$37.70
$533.08kSell
Anatol KreitzerCXO2026-07-17200$38.39
$7.68kSell
Jonathan GillisCFO;CAO;Interim2026-07-17900$38.17
$34.35kSell
Christopher A. KroegerCEO2026-07-1716,779$37.90
$635.92kSell

1 of 16

MPLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MPLT insiders and whales buy or sell their stock.

MPLT Shareholders

What type of owners hold Maplight Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Catalyst4 Inc89.54%40,604,153$609.87MInsider
Novo Holdings A8.13%3,686,622$55.37MInstitution
Holdings A. Novo8.13%3,686,622$55.37MInsider
Fcpm III Services Bv7.12%3,226,400$48.46MInstitution
T Rowe Price Investment Management Inc6.18%2,801,937$42.09MInstitution
Goldman Sachs Group Inc 14.40%1,994,873$29.96MInstitution
Christopher A. Kroeger3.20%1,448,835$21.76MInsider
Blackrock Inc2.95%1,339,731$20.12MInstitution
Blue Owl Capital Holdings LP2.22%1,005,929$15.11MInstitution
Nan Fung Group Holdings Ltd2.14%971,253$14.59MInstitution

1 of 3

MPLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MPLT34.15%65.85%Net BuyingNet Buying
MDXG48.14%51.86%Net BuyingNet Buying
ACHV20.97%16.84%Net Selling
AGMB47.92%0.09%
NVCT17.04%42.88%Net BuyingNet Buying
View Top Biotech Stocks

Maplight Therapeutics Stock Ownership FAQ

Who owns Maplight Therapeutics?

Maplight Therapeutics (NASDAQ: MPLT) is owned by 54.47% institutional shareholders, 105.03% Maplight Therapeutics insiders, and 0.00% retail investors. Catalyst4 Inc is the largest individual Maplight Therapeutics shareholder, owning 40.60M shares representing 89.54% of the company. Catalyst4 Inc's Maplight Therapeutics shares are currently valued at $569.68M.

If you're new to stock investing, here's how to buy Maplight Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.